- USA
- Canada
- Seed
- Web 3
Pappas Capital is a venture capital firm focused on investing in and supporting innovative life science companies that are developing advanced products and technologies to address various human diseases.
Investment Thesis
Pappas Capital Contacts Information
Primary contact
Portfolio
Achillion Pharmaceuticals
Aclara Biosciences
Aer Therapeutics
Afferent Pharmaceuticals
Aktis Oncology
Allievex
Amplyx
Anthera Pharmaceuticals
Arena Pharmaceuticals
ArgoMed
Athersys
Balance Therapeutics
BaroSense
BioAtla
BioSyntech
BrainCells
Calyx Therapeutics
CardioDx
CeNeRx
Cequent Pharmaceuticals
Cerexa
Chimerix
Cognetix
CoLucid Pharmaceuticals
CuraSen Therapeutics
Curzion Pharmaceuticals
Cyclerion Therapeutics
Emerald BioAgriculture
Enlaza Therapeutics
Envisia Therapeutics
FlowCardia
Gentis Therapeutics
IlluminOss
Istari Oncology
Kezar Life Sciences
Liquidia Technologies
Lumena Pharmaceuticals
Marina Biotech
Milestone Pharmaceuticals
Mirati Therapeutics
Mirum Pharmaceuticals
Nereus Biosciences
NuVasive
Optherion
Orphomed
Panacos Pharmaceuticals
Peninsula Pharmaceuticals
Plexigen
Plexxikon
Reneo Pharmaceuticals
Ribometrix
Rotation Medical
Selventa
Sensys Medical
Solu Therapeutics
Sorriso Pharmaceuticals
Spherics
Syndax Pharmaceuticals
Tune Therapeutics
TYRX
Ultragenyx Pharmaceutical
Variagenics
VelosBio